arrow
返回
D

Deborah Finco

pfizer usa

10H指数
25论文数
688被引数
收录论文 9
发表时间
Neutralizing Antibody Validation Testing and Reporting Harmonization
err2023-07-08
err10
errOAAI
errMyler, Heather; Pedras-Vasconcelos, Joao; Lester, Todd; Civoli, Francesca; Xu, Weifeng; Wu, Bonnie; Vainshtein, Inna; Luo, Linlin; Hassanein, Mohamed; Liu, Susana; Ramaswamy, Swarna Suba; Mora, Johanna; Pennucci, Jason; McCush, Fred; Lavelle, Amy; Jani, Darshana; Ambakhutwala, Angela; Baltrukonis, Daniel; Barker, Breann; Carmean, Rebecca; Chung, Shan; Dai, Sheng; DeWall, Stephen; Dholakiya, Sanjay L.; Dodge, Robert; Finco, Deborah; Yan, Haoheng; Hays, Amanda; Hu, Zheng; Inzano, Cynthia; Kamen, Lynn; Lai, Ching-Ha; Meyer, Erik; Nelson, Robert; Paudel, Amrit; Phillips, Kelli; Poupart, Marie-Eve; Qu, Qiang; Abhari, Mohsen Rajabi; Ryding, Janka; Sheldon, Curtis; Spriggs, Franklin; Warrino, Dominic; Wu, Yuling; Yang, Lin; Pasas-Farmer, Stephanie
err分享
err收藏
Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody
err2020-03-17
err4
PREAI
errKernstock, Robert; Sperinde, Gizette; Finco, Deborah; Davis, Roslyn; Montgomery, Diana
err分享
err收藏
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab临床研究中用于检测阿达木单抗和英夫利昔单抗抗药物抗体的免疫测定方法
err2018-03-30
err66
errOAAI
errGorovits, B.; Baltrukonis, D. J.; Bhattacharya, I; Birchler, M. A.; Finco, D.; Sikkema, D.; Vincent, M. S.; Lula, S.; Marshall, L.; Hickling, T. P.
err分享
err收藏
Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions
err2016-09-01
err43
errOAAI
errGrimaldi, Christine; Finco, Deborah; Fort, Madeline M.; Gliddon, Daniel; Harper, Kirsty; Helms, Whitney S.; Mitchell, Jane A.; O'Lone, Raegan; Parish, Stanley T.; Piche, Marie-Soleil; Reed, Daniel M.; Reichmann, Gabriele; Ryan, Patricia C.; Stebbings, Richard; Walker, Mindi
err分享
err收藏
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium标准化术语,定义和概念,用于描述和解释生物制药的有害免疫原性: 创新药物倡议ABIRISK联盟的建议
err2015-07-02
err76
errOAAI
errRup, B.; Pallardy, M.; Sikkema, D.; Albert, T.; Allez, M.; Broet, P.; Carini, C.; Creeke, P.; Davidson, J.; De Vries, N.; Finco, D.; Fogdell-Hahn, A.; Havrdova, E.; Hincelin-Mery, A.; Holland, M. C.; Jensen, P. E. H.; Jury, E. C.; Kirby, H.; Kramer, D.; Lacroix-Desmazes, S.; Legrand, J.; Maggi, E.; Maillere, B.; Mariette, X.; Mauri, C.; Mikol, V.; Mulleman, D.; Oldenburg, J.; Paintaud, G.; Pedersen, C. R.; Ruperto, N.; Seitz, R.; Spindeldreher, S.; Deisenhammer, F.
err分享
err收藏
Cytokine release assays: Current practices and future directions
err2014-04-01
err102
PREAI
errFinco, D.; Grimaldi, C.; Fort, M.; Walker, M.; Kiessling, A.; Wolf, B.; Salcedo, T.; Faggioni, R.; Schneider, A.; Ibraghimov, A.; Scesney, S.; Serna, D.; Prell, R.; Stebbings, R.; Narayanan, P. K.
err分享
err收藏
A multiple-dose toxicity study of tanezumab in cynomolgus monkeys
err2011-03-01
err24
PREAI
errZorbas, Mark; Hurst, Susan; Shelton, David; Evans, Mark; Finco, Deborah; Butt, Mark
err分享
err收藏
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics
err2011-01-01
err42
PREAI
errFinco, Deborah; Baltrukonis, Daniel; Clements-Egan, Adrienne; Delaria, Kathy; Gunn, George R., III; Lowe, John; Maia, Mauricio; Wong, Teresa
err分享
err收藏